BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Business Model:
Revenue: $3.1M
Employees: 2-10
Address: 3711 Market St
City: Philadelphia
State: PA
Zip: 19104
Country: US
BioAdvance provides funding to startup life sciences companies in Southeastern Pennsylvania through its new $50 million Greenhouse Fund. They invest in therapeutics, devices, diagnostics and platform technologies focused on human health. Since its first investments in 2003, BioAdvance has become one of the nation&s;s leading investors providing pre-seed and seed-stage funding. To date they have committed more than $40 million to more than 50 seed-stage companies and 17 pre-seed companies. Their portfolio companies are working to develop products to treat health problems including Alzheimer&s;s disease, cancer, obesity, GI disorders, neurological and respiratory illnesses. BioAdvance was established with $33 million from the Commonwealth of Pennsylvania&s;s share of tobacco settlement monies.
Contact Phone:
+16102300544
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2004 | Sxinos | Seed Round | - |
12/2011 | Melior Discovery | Venture Round | - |
4/2010 | Melior Discovery | Venture Round | - |
6/2007 | Melior Discovery | Venture Round | - |
1/2005 | Melior Discovery | Seed Round | 500k |
8/2019 | Renovacor | Series A | 11M |
8/2017 | Olive Devices | Venture Round | - |
1/2004 | Dynamis Pharmaceuticals | Seed Round | - |
3/2005 | Fox Chase Cancer Center | Seed Round | - |
11/2015 | Enzium | Venture Round | - |
5/2013 | Enzium | Seed Round | 750k |
4/2015 | Enzium | Venture Round | - |
12/2012 | Merganser Biotech | Seed Round | - |
9/2017 | Oncora Medical | Seed Round | 1.3M |
1/2014 | Merganser Biotech | Series A | - |
4/2013 | Merganser Biotech | Seed Round | - |
6/2015 | Galleon Pharmaceuticals | Series B | 10M |
3/2008 | Vindico Medical Education | Seed Round | - |
7/2022 | Halo Labs | Series C | 0 |
8/2017 | Palvella Therapeutics | Venture Round | - |
9/2017 | Opsidio | Venture Round | 500k |
1/2012 | RMH Sciences | Seed Round | - |
5/2005 | EyeIC | Seed Round | - |
3/2008 | Phoenix S&a;T | Seed Round | - |
12/2011 | Solaris Therapeutics | Seed Round | - |
10/2016 | Immunome | Series A | 7.2M |
1/2018 | Allevi | Venture Round | - |
6/2012 | Ceptaris Therapeutics | Series D | 10M |
4/2011 | Halo Labs | Seed Round | - |
1/2010 | Jenrin Discovery | Venture Round | - |
5/2020 | Palvella Therapeutics | Series C | 0 |
2/2017 | Keriton | Seed Round | 0 |
5/2007 | Avid Radiopharmaceuticals | Series C | 0 |
9/2011 | Penn-Greene | Seed Round | - |
11/2003 | Advaxis | Seed Round | - |
9/2011 | Solaris Therapeutics | Seed Round | - |
11/2010 | Ceptaris Therapeutics | Debt Financing | 2M |
11/2016 | Cohero Health | Series A | 0 |
3/2015 | TowerView Health | Seed Round | 200k |
2/2005 | Marillion Pharmaceuticals | Seed Round | - |
1/2005 | SansRosa Pharmaceuticals | Venture Round | 500k |
12/2015 | Cohero Health | Seed Round | 0 |
5/2014 | Relmada Therapeutics | Venture Round | 15.1M |
2/2004 | Relmada Therapeutics | Seed Round | - |
3/2004 | PhenoTech | Seed Round | - |
5/2013 | OSSIANIX | Seed Round | - |
7/2010 | Novira Therapeutics | Venture Round | - |
7/2012 | Treventis | Seed Round | - |
10/2014 | OSSIANIX | Venture Round | - |
12/2011 | Niiki Pharma | Venture Round | - |
9/2010 | Niiki Pharma | Venture Round | - |
1/2009 | Niiki Pharma | Debt Financing | 5M |
7/2008 | Niiki Pharma | Seed Round | - |
9/2009 | Immunome | Seed Round | 435.4k |
6/2016 | Penn State Health | Seed Round | - |
1/2012 | Galleon Pharmaceuticals | Venture Round | - |
6/2004 | Protez Pharmaceuticals | Venture Round | - |
7/2003 | Alteris Therapeutics | Seed Round | - |
1/2005 | Galleon Pharmaceuticals | Seed Round | 500k |
10/2021 | Phrase Health | Seed Round | 0 |
6/2008 | Neuro Innovations | Seed Round | - |
8/2013 | Microbiota | Seed Round | - |
3/2005 | Marillion Pharmaceuticals | Venture Round | 500k |
1/2020 | Ride Health | Seed | 6.2M |
6/2018 | Bainbridge Health | Seed Round | 0 |
4/2006 | Midway Pharmaceuticals | Seed Round | 500k |
11/2013 | Immunome | Venture Round | - |
2/2013 | Immunome | Venture Round | 445k |
10/2014 | Immunome | Venture Round | 467.5k |
6/2011 | Immunome | Venture Round | 846.6k |
9/2010 | Immunome | Venture Round | - |
11/2008 | Midway Pharmaceuticals | Venture Round | - |
2/2015 | Merganser Biotech | Series A | 28M |
8/2017 | Genome Profiling | Venture Round | 880k |
10/2005 | NuPathe | Seed Round | - |
10/2010 | Jenrin Discovery | Venture Round | - |
9/2018 | ENB Therapeutics | Series A | 8.1M |
7/2009 | Novira Therapeutics | Seed Round | 2.5M |
10/2004 | Acuity Pharmaceuticals | Series B | 0 |
12/2022 | Senzo | Seed Round | 1.9M |
8/2017 | TalexMedical | Seed Round | 500k |
4/2020 | Halo Labs | Series B | 12M |
8/2005 | Protez Pharmaceuticals | Series B | 15M |
9/2006 | NuPathe | Series A | 15M |
6/2010 | Novira Therapeutics | Venture Round | - |
2/2005 | SansRosa Pharmaceuticals | Seed Round | - |
1/2010 | Novira Therapeutics | Venture Round | - |
11/2010 | Solaris Therapeutics | Seed Round | - |
2/2012 | Solaris Therapeutics | Seed Round | - |
3/2015 | Jenrin Discovery | Venture Round | - |
12/2012 | Jenrin Discovery | Seed Round | 520k |
3/2005 | Vasculab | Seed Round | - |
3/2010 | Temple University | Seed Round | - |
11/2004 | LumenVu | Seed Round | - |
10/2005 | SonoMedix | Seed Round | - |
8/2012 | Anakim | Seed Round | - |
10/2016 | Genome Profiling | Seed Round | - |
1/2015 | Hsiri Therapeutics | Seed Round | - |
1/2004 | Cira Discovery Sciences | Seed Round | - |
8/2017 | Wellsheet | Seed Round | 0 |
5/2009 | Avid Radiopharmaceuticals | Series D | 0 |
5/2019 | Pillo Health | Series A | 0 |
3/2016 | Oncora Medical | Seed Round | 1.3M |
1/2023 | Palvella Therapeutics | Series D | 37.7M |
4/2007 | Jenrin Discovery | Venture Round | - |
11/2006 | Ceptaris Therapeutics | Series B | 4.5M |
7/2017 | Venatorx Pharmaceuticals | Series B | 42M |
3/2016 | Mebias Discovery | Seed Round | - |
4/2010 | Annovis Bio | Debt Financing | 706.1k |
9/2016 | Jenrin Discovery | Venture Round | - |
12/2016 | Jenrin Discovery | Venture Round | - |
9/2022 | Innervace | Series A | 40M |
5/2014 | BioDetego | Seed Round | - |
8/2017 | Group K Diagnostics | Seed Round | 371.3k |
10/2004 | Wistar Institute | Seed Round | - |
10/2010 | Ceptaris Therapeutics | Venture Round | - |
2/2004 | Ceptaris Therapeutics | Venture Round | 500k |
12/2008 | Marillion Pharmaceuticals | Venture Round | - |
1/2005 | Avid Radiopharmaceuticals | Seed Round | 500k |
7/2008 | NuPathe | Series B | 30M |
6/2004 | Acuity Pharmaceuticals | Venture Round | - |
1/2013 | Life Mist Technologies | Seed Round | - |
11/2013 | Venatorx Pharmaceuticals | Series A | 3.4M |
7/2005 | Immune Control | Series A | 0 |
8/2005 | Avid Radiopharmaceuticals | Series A | - |
4/2007 | StageMark | Series B | 1.6M |
2/2016 | RiboNova Inc. | Seed Round | - |
2/2017 | Mebias Discovery | Venture Round | - |
3/2013 | Novira Therapeutics | Series A | 0 |
2/2016 | Enzium | Seed Round | - |
7/2012 | Relmada Therapeutics | Series A | 3M |
6/2020 | Wellsheet | Series A | 0 |
3/2014 | InfraScan | Seed Round | - |
10/2005 | InfraScan | Seed Round | 500k |
7/2016 | Enzium | Venture Round | - |
9/2015 | Allevi | Seed Round | 1.3M |
8/2017 | WellTrackONE | Venture Round | 200k |
12/2004 | Cira Discovery Sciences | Seed Round | - |
7/2016 | Bainbridge Health | Seed Round | - |
9/2010 | Novira Therapeutics | Seed Round | - |
5/2005 | NexusPharma | Seed Round | - |
3/2005 | Jenrin Discovery | Seed Round | - |
12/2014 | Novira Therapeutics | Debt Financing | 9M |
12/2010 | Leversense | Debt Financing | 399k |
3/2012 | CarePartners Plus | Seed Round | 592.4k |
5/2003 | Retinapharma Technologies | Seed Round | - |
7/2010 | Phoenix S&a;T | Debt Financing | 50k |
12/2015 | Hsiri Therapeutics | Venture Round | - |
10/2014 | Relmada Therapeutics | Post-IPO Equity | - |
5/2007 | Marillion Pharmaceuticals | Venture Round | - |
1/2009 | Novira Therapeutics | Seed Round | - |
6/2016 | Olive Devices | Venture Round | - |
1/2012 | Immunome | Seed Round | 145k |
7/2012 | Innovative Supply Solutions | Venture Round | - |
4/2010 | Innovative Supply Solutions | Seed Round | - |
11/2012 | Innovative Supply Solutions | Venture Round | - |
9/2014 | Jenrin Discovery | Venture Round | - |
1/2006 | Avid Radiopharmaceuticals | Series A | 0 |
5/2016 | Jenrin Discovery | Venture Round | - |
6/2016 | Cohero Health | Venture Round | - |
11/2008 | InfraScan | Seed Round | - |
5/2017 | Ride Health | Seed Round | - |
10/2015 | CarePartners Plus | Venture Round | - |
6/2012 | Melior Discovery | Venture Round | - |
9/2016 | Mebias Discovery | Venture Round | - |
1/2019 | Phrase Health | Pre Seed Round | - |
3/2009 | Treventis | Seed Round | 550k |
7/2022 | Senzo | Seed Round | 0 |
8/2011 | Niiki Pharma | Venture Round | 1.7M |
3/2010 | Niiki Pharma | Debt Financing | 3.8M |
10/2011 | Niiki Pharma | Venture Round | - |
12/2012 | Niiki Pharma | Venture Round | - |
5/2012 | Cool-Bio | Seed Round | - |
8/2017 | Cytovas | Venture Round | - |
3/2005 | InfraScan | Seed Round | - |
6/2012 | Halo Labs | Seed Round | 750k |
6/2003 | Eagle Vision Pharmaceutical | Seed Round | - |
6/2013 | Annovis Bio | Seed Round | 350k |
8/2015 | WellTrackONE | Series A | 1.5M |
11/2013 | Halo Labs | Seed Round | - |
5/2012 | Imiplex | Seed Round | - |
2/2017 | Pillo Health | Seed Round | 1.5M |
3/2022 | KayoThera | Series A | 8M |
4/2015 | HealthQx | Series B | 3.7M |
5/2014 | HealthQx | Series A | 3M |
12/2018 | Halo Labs | Series B | 5.6M |
5/2016 | Noble | Seed Round | 1.4M |
8/2010 | Formae | Seed Round | - |
7/2008 | Formae | Seed Round | - |
6/2014 | Halo Labs | Seed Round | - |
11/2008 | Eagle Vision Pharmaceutical | Seed Round | - |
5/2003 | Gelifex | Seed Round | - |
5/2005 | MicroMRI | Seed Round | - |
11/2010 | Eagle Vision Pharmaceutical | Seed Round | - |
7/2022 | Senzo | Seed Round | 0 |
7/2022 | Halo Labs | Series C | 0 |
3/2022 | KayoThera | Series A | 0 |
10/2021 | Phrase Health | Seed Round | 0 |
6/2020 | Wellsheet | Series A | 0 |
5/2020 | Palvella Therapeutics | Series C | 0 |
4/2020 | Halo Labs | Series B | 0 |
1/2020 | Ride Health | Seed Round | 0 |
8/2019 | Renovacor | Series A | 0 |
5/2019 | Pillo Health | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|